The collaboration between CGBIO and NDR Medical Technology has been made to introduce an AI robotic intervention device.
FREMONT, CA: To introduce an AI robotic intervention device, collaboration is made between NDR Medical Technology, a Singaporean AI medical device maker, and CGBIO, a regenerative medicine company in South Korea. NDR Medical Technology which was established in 2015 has developed the world's first patented automated needle targeting (ANT) system that provides accurate and sale needle punctures to human organs, such as the pancreas, lungs, spine, and kidneys. This system combines medical image processing and AI to assist surgeons during minimally invasive surgery.
An interventional robot integrates CT imaging and C-arm fluoroscopy for percutaneous needle placement, which is located at the core of the system. NDR's website states that this device allows surgeons to focus entirely on controlling the depth of insertion as it automates calibration and the needle alignment with a single x-ray image within a few seconds. NDR emphasizes that with this device there will be less radiation exposure for both clinicians and patients as the quick needle alignment renders less fluoroscopic time. ANT-X system has already undergone clinical studies in Japan and other Southeast Asian countries and has received its CE certification in Europe.
In order to assess a patient's anatomy and conduct trajectory path alignment in placing a needle from the insertion point to the selected point, many clinicians are still performing interventional procedures based on a separate program, states CGBIO. Further,under this latest partnership CGBIO will conduct clinical trials with doctors in South Korea who manufactures and distributes products and solutions for spinal disorders and wound management. This trail will expand the utilization of the ANT-X system in various areas of interventional procedures requiring percutaneous needle placement, such as orthopedics, neurosurgery, and urology.